 | • レポートコード：MRC2-11QY04210 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経皮経管冠動脈形成術（PTCA）製品のグローバル市場について調査・分析したレポートです。種類別（PTCAバルーン、PTCAガイド）市場規模、用途別（OEM、アフターマーケット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経皮経管冠動脈形成術（PTCA）製品の競争状況、市場シェア ・世界の経皮経管冠動脈形成術（PTCA）製品市場：種類別市場規模 2015年-2020年（PTCAバルーン、PTCAガイド） ・世界の経皮経管冠動脈形成術（PTCA）製品市場：種類別市場規模予測 2021年-2026年（PTCAバルーン、PTCAガイド） ・世界の経皮経管冠動脈形成術（PTCA）製品市場：用途別市場規模 2015年-2020年（OEM、アフターマーケット） ・世界の経皮経管冠動脈形成術（PTCA）製品市場：用途別市場規模予測 2021年-2026年（OEM、アフターマーケット） ・北米の経皮経管冠動脈形成術（PTCA）製品市場分析：米国、カナダ ・ヨーロッパの経皮経管冠動脈形成術（PTCA）製品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経皮経管冠動脈形成術（PTCA）製品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経皮経管冠動脈形成術（PTCA）製品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経皮経管冠動脈形成術（PTCA）製品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Terumo、Boston Scientific、Intact Vascular、Asahi Intecc、Angioscore、Bard PV、Cook Medical、Cordis、Medtronic、Biosensors International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.
Market Analysis and Insights: Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Scope and Market Size
Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Terumo
Boston Scientific
Intact Vascular
Asahi Intecc
Angioscore
Bard PV
Cook Medical
Cordis
Medtronic
Biosensors International
Market segment by Type, the product can be split into
PTCA ballon
PTCA guide
Market segment by Application, split into
OEMS
Aftermarket
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue
1.4 Market by Type
1.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PTCA ballon
1.4.3 PTCA guide
1.5 Market by Application
1.5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application: 2020 VS 2026
1.5.2 OEMS
1.5.3 Aftermarket
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Perspective (2015-2026)
2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Growth Trends by Regions
2.2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Share by Regions (2015-2020)
2.2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Strategy
2.3.6 Primary Interviews with Key Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Market Size
3.1.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue (2015-2020)
3.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Players (2015-2020)
3.1.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio
3.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2019
3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players Head office and Area Served
3.4 Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service
3.5 Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Type (2015-2020)
4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
5.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
6.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in North America (2019-2020)
6.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
6.4 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
7 Europe
7.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
7.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in Europe (2019-2020)
7.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
7.4 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
8 China
8.1 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
8.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in China (2019-2020)
8.3 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
8.4 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
9 Japan
9.1 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
9.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in Japan (2019-2020)
9.3 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
9.4 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
10.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
10.4 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
11 India
11.1 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
11.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in India (2019-2020)
11.3 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
11.4 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2015-2020)
12.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players in Central & South America (2019-2020)
12.3 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020)
12.4 Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.1.4 Abbott Laboratories Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Terumo
13.2.1 Terumo Company Details
13.2.2 Terumo Business Overview
13.2.3 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.2.4 Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.2.5 Terumo Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview
13.3.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.3.4 Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 Intact Vascular
13.4.1 Intact Vascular Company Details
13.4.2 Intact Vascular Business Overview
13.4.3 Intact Vascular Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.4.4 Intact Vascular Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.4.5 Intact Vascular Recent Development
13.5 Asahi Intecc
13.5.1 Asahi Intecc Company Details
13.5.2 Asahi Intecc Business Overview
13.5.3 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.5.4 Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.5.5 Asahi Intecc Recent Development
13.6 Angioscore
13.6.1 Angioscore Company Details
13.6.2 Angioscore Business Overview
13.6.3 Angioscore Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.6.4 Angioscore Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.6.5 Angioscore Recent Development
13.7 Bard PV
13.7.1 Bard PV Company Details
13.7.2 Bard PV Business Overview
13.7.3 Bard PV Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.7.4 Bard PV Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.7.5 Bard PV Recent Development
13.8 Cook Medical
13.8.1 Cook Medical Company Details
13.8.2 Cook Medical Business Overview
13.8.3 Cook Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.8.4 Cook Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.8.5 Cook Medical Recent Development
13.9 Cordis
13.9.1 Cordis Company Details
13.9.2 Cordis Business Overview
13.9.3 Cordis Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.9.4 Cordis Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.9.5 Cordis Recent Development
13.10 Medtronic
13.10.1 Medtronic Company Details
13.10.2 Medtronic Business Overview
13.10.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
13.10.4 Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
13.10.5 Medtronic Recent Development
13.11 Biosensors International
10.11.1 Biosensors International Company Details
10.11.2 Biosensors International Business Overview
10.11.3 Biosensors International Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
10.11.4 Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020)
10.11.5 Biosensors International Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Market Segments
Table 2. Key Players Covered: Ranking by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue
Table 3. Ranking of Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PTCA ballon
Table 6. Key Players of PTCA guide
Table 7. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Regions (2015-2020)
Table 11. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Strategy
Table 17. Main Points Interviewed from Key Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players
Table 18. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue by Players (2015-2020) (Million US$)
Table 19. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Players (2015-2020)
Table 20. Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products as of 2019)
Table 21. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service
Table 24. Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 27. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Share by Type (2015-2020)
Table 28. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Type (2021-2026)
Table 29. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Share by Application (2015-2020)
Table 30. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 31. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Share by Application (2021-2026)
Table 32. North America Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 34. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 35. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 36. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 37. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 38. Europe Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 40. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 42. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 44. China Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 45. China Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 46. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 47. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 48. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 49. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 50. Japan Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 52. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 54. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 58. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 60. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 62. India Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 63. India Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 64. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 65. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 66. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 67. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share (2019-2020)
Table 70. Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type (2015-2020)
Table 72. Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Terumo Company Details
Table 80. Terumo Business Overview
Table 81. Terumo Product
Table 82. Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 83. Terumo Recent Development
Table 84. Boston Scientific Company Details
Table 85. Boston Scientific Business Overview
Table 86. Boston Scientific Product
Table 87. Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 88. Boston Scientific Recent Development
Table 89. Intact Vascular Company Details
Table 90. Intact Vascular Business Overview
Table 91. Intact Vascular Product
Table 92. Intact Vascular Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 93. Intact Vascular Recent Development
Table 94. Asahi Intecc Company Details
Table 95. Asahi Intecc Business Overview
Table 96. Asahi Intecc Product
Table 97. Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 98. Asahi Intecc Recent Development
Table 99. Angioscore Company Details
Table 100. Angioscore Business Overview
Table 101. Angioscore Product
Table 102. Angioscore Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 103. Angioscore Recent Development
Table 104. Bard PV Company Details
Table 105. Bard PV Business Overview
Table 106. Bard PV Product
Table 107. Bard PV Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 108. Bard PV Recent Development
Table 109. Cook Medical Business Overview
Table 110. Cook Medical Product
Table 111. Cook Medical Company Details
Table 112. Cook Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 113. Cook Medical Recent Development
Table 114. Cordis Company Details
Table 115. Cordis Business Overview
Table 116. Cordis Product
Table 117. Cordis Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 118. Cordis Recent Development
Table 119. Medtronic Company Details
Table 120. Medtronic Business Overview
Table 121. Medtronic Product
Table 122. Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 123. Medtronic Recent Development
Table 124. Biosensors International Company Details
Table 125. Biosensors International Business Overview
Table 126. Biosensors International Product
Table 127. Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2015-2020) (Million US$)
Table 128. Biosensors International Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Type: 2020 VS 2026
Figure 2. PTCA ballon Features
Figure 3. PTCA guide Features
Figure 4. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Application: 2020 VS 2026
Figure 5. OEMS Case Studies
Figure 6. Aftermarket Case Studies
Figure 7. Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Report Years Considered
Figure 8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Regions: 2020 VS 2026
Figure 10. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Players in 2019
Figure 13. Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2019
Figure 15. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
経皮的冠動脈インターベンションの世界市場（～2026年） Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visual…- 経皮的腎結石切除システムの世界市場（～2026年） Percutaneous nephrolithotomy (PCNL) is the surgical standard for treating large or complex renal stones. The complexity of the stone treated can be quantified using a variety of validated nephrolithometry classification systems. Increasing familiarity with the supine approach to PCNL has enabled sim…
- 急性冠症候群（ACS）の世界市場（～2026年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…
- 冠動脈画像の世界市場（～2026年） Coronary Artery disease (CAD) is a cardiovascular disorder which is caused by reduced flow or absent of blood flow in arteries that enclose and supply the heart which is commonly known as Ischemia. Usually in a coronary artery, due to deposition of fat, cholesterol, and calcium forms a thick layer i…
- 生体吸収性冠動脈ステントの世界市場（～2026年） Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these ful…